| |
| |
|
| Insider
Information: |
Balo Andrew K |
| Relationship: |
EVP Regulatory Strateg... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
50,908 |
|
|
Indirect Shares
|
30,212 |
|
|
| Direct
Value |
$6,484,661 |
|
|
|
Indirect Value
|
$3,848,405 |
|
|
| Total
Shares |
81,120 |
|
|
| Total
Value |
$10,333,066 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 90.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Regulatory Strateg... |
2023-03-10 |
50,908 |
2023-03-10 |
30,212 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
200 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
VP of Clinical and RegulatoryO |
• – – |
2005-04-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,500 |
|
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,477 |
107,680 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
18,774 |
18,774 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-06-03 |
4 |
AS |
$0.00 |
$0 |
D/D |
(18,774) |
16,533 |
0 |
% |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,498 |
13,150 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-09-09 |
4 |
AS |
$0.00 |
$0 |
D/D |
(2,498) |
14,056 |
0 |
% |
|
| DXCM |
DexCom Inc |
* |
• – – |
2021-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,301 |
40,873 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Global Medical Affairs |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
4,984 |
19,045 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2020-03-08 |
4 |
A |
$0.00 |
$9 |
D/D |
8,811 |
66,749 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$15 |
D/D |
14,987 |
88,134 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-03-08 |
4 |
A |
$0.00 |
$29 |
D/D |
28,761 |
132,663 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2016-03-08 |
4 |
A |
$0.00 |
$38 |
D/D |
38,000 |
145,777 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-03-08 |
4 |
A |
$0.00 |
$39 |
D/D |
38,502 |
118,086 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2011-03-08 |
4 |
A |
$0.00 |
$44 |
D/D |
43,750 |
49,510 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-03-08 |
4 |
A |
$0.00 |
$48 |
D/D |
47,500 |
197,756 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2013-03-11 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
154,218 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2014-03-08 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
174,485 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2012-03-08 |
4 |
A |
$0.00 |
$54 |
D/D |
53,750 |
103,622 |
0 |
- |
|
| DXCM |
DexCom Inc |
* |
• – – |
2019-09-03 |
4 |
AS |
$170.00 |
$6,290 |
D/D |
(37) |
69,409 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-02-10 |
4 |
OE |
$9.80 |
$7,125 |
D/D |
727 |
107,072 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2013-03-13 |
4 |
OE |
$0.50 |
$7,708 |
D/D |
15,416 |
159,987 |
0 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2008-11-21 |
4 |
B |
$1.51 |
$10,720 |
I/I |
7,000 |
7,000 |
1.99 |
- |
|
| DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
• – – |
2012-05-18 |
4 |
OE |
$0.50 |
$14,233 |
D/D |
28,466 |
126,506 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-11-24 |
4 |
OE |
$3.19 |
$15,312 |
D/D |
4,800 |
117,957 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-09-07 |
4 |
OE |
$3.19 |
$15,947 |
D/D |
4,999 |
135,009 |
0 |
- |
|
200 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
